Mechanism and role of nuclear entry in HIV-1 replication

Information

  • Research Project
  • 9031054
  • ApplicationId
    9031054
  • Core Project Number
    R01AI100720
  • Full Project Number
    4R01AI100720-05
  • Serial Number
    100720
  • FOA Number
    PA-11-260
  • Sub Project Id
  • Project Start Date
    4/1/2012 - 12 years ago
  • Project End Date
    3/31/2017 - 7 years ago
  • Program Officer Name
    KUO, LILLIAN S.
  • Budget Start Date
    4/1/2016 - 8 years ago
  • Budget End Date
    3/31/2017 - 7 years ago
  • Fiscal Year
    2016
  • Support Year
    05
  • Suffix
  • Award Notice Date
    3/29/2016 - 8 years ago

Mechanism and role of nuclear entry in HIV-1 replication

DESCRIPTION (provided by applicant): The ability of HIV-1 to utilize the cellular machinery for nuclear entry allows the virus to infect resting CD4+ T cells and tissue macrophages, the two non-dividing cell types believed to play critical roles in HIV-1 transmission, persistence and pathogenesis. However, the precise mechanism and specific requirement of nuclear entry in HIV-1 replication remains unclear. Capsid is the major determinant for HIV-1 infection of non-dividing cells but also dictates the dependence of HIV-1 on TNPO3, a host molecule recently implicated in HIV-1 nuclear entry. Our preliminary studies found a perfect correlation between the dependence of HIV-1 capsid mutants on TNPO3 and their ability to infect non-dividing cells. The hypothesis being tested in this project is that the capsid protein regulates HIV-1 nuclear entry by assisting intracellular virus complexes in hijacking the TNPO3-dependent cellular machinery and this ability is critical for HIV-1 replication in vivo. In Aim 1, we will determine hw the HIV-1 capsid protein determines TNPO3 usage by HIV-1 and how TNPO3 and other host factors promote HIV-1 nuclear entry. We will next define the specific requirement of this TNPO3-dependent nuclear entry for HIV-1 replication in vivo. In Aim 2, we will study a unique case of HIV-1 capsid evolution in patients carrying the HLA-B27. Preliminary data suggests recurrent selection of TNPO3- dependent viruses in these patients. In Aim 3, we will combine our genetic data with a well-studied macaque model of HIV-1 by using simian immunodeficiency virus (SIV) to directly address the importance of nuclear entry in vivo. Here we will generate and utilize TNPO3-independent SIV mutants, which either retain or lose the ability to infect non-dividing cells. Successful completion of this proposed research will help us understand the mechanism by which HIV-1 exploits the nuclear transport machinery to maximize its propagation.

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    R01
  • Administering IC
    AI
  • Application Type
    4
  • Direct Cost Amount
    250000
  • Indirect Cost Amount
    195500
  • Total Cost
    445500
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    855
  • Ed Inst. Type
  • Funding ICs
    NIAID:445500\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    AMCB
  • Study Section Name
    AIDS Molecular and Cellular Biology Study Section
  • Organization Name
    AARON DIAMOND AIDS RESEARCH CENTER
  • Organization Department
  • Organization DUNS
    786658872
  • Organization City
    NEW YORK
  • Organization State
    NY
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    100169102
  • Organization District
    UNITED STATES